Loading...

Home
Stock
RJF

RJF Overview

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

Loading chart...

High

168.500

Open

168.500

VWAP

167.69

Vol

849.16K

Mkt Cap

32.66B

Low

166.965

Amount

142.39M

EV/EBITDA(TTM)

8.81

Total Shares

194.88M

EV

26.62B

EV/OCF(TTM)

10.33

P/S(TTM)

2.10

Raymond James Financial, Inc. is a diversified financial services company that provides services to individuals, corporations and municipalities. The Company's segments include Private Client Group (PCG), Capital Markets, Asset Management, Bank and Other. PCG segment provides financial planning, investment advisory, and securities transaction services to clients through financial advisors. Capital Markets segment conducts investment banking, institutional sales, securities trading, equity research, and the syndication and management of investments in low-income housing funds and funds of a similar nature. Asset Management segment provides asset management, portfolio management and related administrative services to retail and institutional clients. Bank segment includes Raymond James Bank, a Florida-chartered state member bank, and TriState Capital Bank, a Pennsylvania-chartered state member bank. Other segment includes corporate cash balances and its private equity investments.

Show More

Events Timeline

(ET)

2026-05-20

16:30:00

Client Assets Under Administration Reach Record $1.87 Trillion

2026-04-22 (ET)

2026-04-22

16:20:00

Company Reports Q2 Revenue of $3.86B

News

CNBC

Wall Street's Major Banks Bullish on SpaceX's Future

Analysts' Optimistic Outlook: Deutsche Bank analysts describe SpaceX as 'the apex of civilizational ambition,' indicating strong confidence in the company's future role in shaping history and technological advancement.
Market Capitalization: With a market cap of $2.1 trillion and a closing price of $160.42 per share on Monday, SpaceX's performance post-IPO reflects market approval, although MoffettNathanson remains pessimistic about its value over the next 12 months.
Technological Innovation Potential: Analysts at Raymond James assert that the successful deployment of Starship will industrialize orbital transportation, potentially reducing launch costs to hundreds of dollars per kilogram, thereby advancing the broader space economy.
Diversified Business Strategy: SpaceX's integration strategy across its three business segments—Space, Connectivity, and Artificial Intelligence—is expected to enhance its competitive edge in future markets, particularly as Starlink's user base has reached 12 million, becoming a significant revenue driver.

CNBC

Market Update: SpaceX and Coca-Cola Reach New Highs

SpaceX Joins Nasdaq: SpaceX was fast-tracked into the Nasdaq-100 on Tuesday, closing its first trading day at $160.95, approximately 30% below its June 16 high of $225.64, indicating strong market interest despite the decline.
Financial Sector Surge: The S&P Financials sector surged 4.5% in the past week and 7.6% over the month, with 82 out of 85 stocks rising last week, led by Robinhood's impressive 43% increase over three months, reflecting renewed investor confidence in financial stocks.
Coca-Cola Hits New High: Coca-Cola shares have risen 7.4% over the past three months, reaching a new high, while the S&P Staples sector remained flat, showcasing Coca-Cola's robust performance and stable consumer demand in a challenging market.
Cybersecurity Stocks Reach All-Time Highs: CrowdStrike, Fortinet, and Palo Alto Networks all achieved record highs on Monday, with CrowdStrike up 100%, Fortinet up 97%, and Palo Alto Networks up 121% over three months, highlighting strong market interest and investment in cybersecurity solutions.

Fool

AppLovin Shares Surge Following Analyst Upgrade

Analyst Strong Buy: Andrew Marok of Raymond James initiated coverage on AppLovin with a strong buy rating and a price target of $640 per share, over 21% higher than its recent closing price, which has contributed to a more than 10% rise in shares over the past week.
Optimistic Market Outlook: Marok's bullish view on the e-commerce advertising market's expansion is favorable for AppLovin, especially after the company opened its self-serve advertising platform in late June, attracting a broader range of advertisers and enhancing its competitive position.
Revenue Growth Expectations: The analyst anticipates revenue growth exceeding 40% for AppLovin, with EBITDA margins surpassing 80%, indicating the company's strong profitability and market potential in the ad tech sector.
Dual Threat Strategy: AppLovin is rapidly becoming a dual threat with its core mobile app advertising business and ongoing expansion into e-commerce, creating a high-growth combination that positions the company strongly in future markets.

NASDAQ.COM

07-03NASDAQ.COM

AppLovin Receives Strong Buy Rating Amid E-commerce Expansion

Analyst Strong Buy: Andrew Marok from Raymond James initiated coverage on AppLovin with a strong buy rating and a price target of $640 per share, representing a 21% upside from its recent closing price, reflecting strong confidence in the company's growth prospects.
E-commerce Platform Opened: In late June, AppLovin opened its self-serve advertising platform to all advertisers, previously requiring referrals, significantly expanding its market reach, particularly in the rapidly growing e-commerce sector.
Revenue Growth Expectations: Marok anticipates over 40% revenue growth for AppLovin, with EBITDA margins exceeding 80%, indicating substantial potential for profitability as the company capitalizes on the e-commerce advertising market.
Dual Threat Strategy: AppLovin is excelling in mobile app advertising while also pushing into e-commerce advertising, creating a high-growth potential combination; despite its high valuation, the market remains optimistic about its future performance.

NASDAQ.COM

06-29NASDAQ.COM

ADMA Biologics Shows Promising Profitability Outlook

Profitability Growth: ADMA Biologics reported a net income of $407 million in Q1, reflecting a 22% year-over-year increase, indicating sustained profitability that is expected to enhance the company's competitive edge in the biopharmaceutical market.
Significant Market Potential: Currently capturing only 4% of its total addressable market, ADMA is positioned for substantial growth, with the market projected to expand at a compound annual growth rate of 10% through 2033, suggesting significant revenue growth opportunities ahead.
Optimistic Product Outlook: EyePoint Pharmaceuticals is on track to announce results from clinical trials for Duravyu, targeting wet age-related macular degeneration, with a market opportunity exceeding $15 billion, which could significantly elevate the company's market position if approved.
Investment Risks and Rewards: Viking Therapeutics has an average price target 146% above its current share price, and while it remains unprofitable, its potential in obesity drug development makes it a focal point for investors, despite the inherent investment risks.

Fool

SpaceX's $2 Trillion Valuation Faces Significant Hurdles Ahead

SpaceX Valuation Analysis: Despite SpaceX's market cap hovering around $2 trillion, the company generated only $18.7 billion in revenue last year and posted a nearly $5 billion loss, indicating the fragility of its high valuation and making a doubling of its stock price over the next two to three years highly unlikely.
ADMA Biologics Profit Growth: ADMA Biologics reported a net income of $407 million in Q1, up 22% year-over-year, with its flagship product Asceniv accounting for approximately 86% of total revenue, showcasing strong growth potential in the plasma-derived immunoglobulin market.
EyePoint Pharmaceuticals Clinical Prospects: EyePoint Pharmaceuticals expects to announce top-line results for Duravyu soon, targeting wet age-related macular degeneration with a market opportunity exceeding $15 billion; analysts are overwhelmingly bullish, with a consensus price target 165% higher than the current share price.
Viking Therapeutics Potential Breakthrough: Viking Therapeutics is conducting two Phase 3 trials for VK2735, and although it is currently unprofitable, its pipeline includes multiple promising therapies, with the average price target for the stock indicating a potential upside of 146%, reflecting significant growth potential.

Wall Street analysts forecast RJF stock price to rise

9 Analyst Rating

Wall Street analysts forecast RJF stock price to rise

2 Buy

7 Hold

0 Sell

Hold

Current: 0.000

Low

176.00

Averages

184.00

High

196.00

Current: 0.000

Low

176.00

Averages

184.00

High

196.00

TD Cowen

Hold

downgrade

$159 -> $155

AI Analysis

2026-05-28

Reason

TD Cowen

Price Target

$159 -> $155

AI Analysis

2026-05-28

downgrade

Hold

Reason

TD Cowen lowered the firm's price target on Raymond James to $155 from $159 and keeps a Hold rating on the shares. The firm lowered its estimates and said the update was collectively disappointing, and they remain watchful on B/S liquidity, NNA economics, margins while no closure on agentic AI terminal value angst, aka "TV-itis".

Morgan Stanley

Equal Weight

maintain

$171 -> $172

2026-04-28

Reason

Morgan Stanley

Price Target

$171 -> $172

2026-04-28

maintain

Equal Weight

Reason

Morgan Stanley raised the firm's price target on Raymond James to $172 from $171 and keeps an Equal Weight rating on the shares. The firm raised its calendar year 2026 and 2027 EPS estimates 7.2% and 0.4%, respectively, on better investment banking revenue and net interest income expectations, partially offset by higher expenses.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for RJF

Unlock Now

Valuation Metrics

The current forward P/E ratio for Raymond James Financial Inc (RJF.N) is 12.30, compared to its 5-year average forward P/E of 12.77. For a more detailed relative valuation and DCF analysis to assess Raymond James Financial Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

12.77

Current PE

12.30

Overvalued PE

14.36

Undervalued PE

11.18

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

9.38

Current EV/EBITDA

7.70

Overvalued EV/EBITDA

11.91

Undervalued EV/EBITDA

6.86

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

1.92

Current PS

1.93

Overvalued PS

2.12

Undervalued PS

1.72

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

money market funds

Intellectia · 68 candidates

Market Cap: >= 1000.00MRegion: USBeta: LowRisk, NegativeBetaList Exchange: XNYS, XNAS, XASEYear Price Change Pct: $2.00 - $8.00Monthly Average Dollar Volume: >= 100,000

Ticker

Name

Market Cap$

Coca-Cola Co

321.48B

Philip Morris International Inc

252.94B

AT&T Inc

201.96B

Chubb Ltd

126.84B

Southern Co

106.81B

Duke Energy Corp

100.69B

5 nejlepších akcií pro dlouhodobé investování

Intellectia · 41 candidates

Beta: LowRisk, ModerateRiskRevenue 5yr Cagr: >= 8Pe Ttm: 10 - 30Return On Equity: >= 15.0%Is Index Component: GSPC

Ticker

Name

Market Cap$

Las Vegas Sands Corp

38.11B

ONEOK Inc

52.13B

NRG Energy Inc

38.42B

Expedia Group Inc

26.43B

Paycom Software Inc

6.83B

Morgan Stanley

264.39B

Give me 10 stocks to buy on Monday

Intellectia · 31 candidates

Pe Ttm: 8 - 28List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA200Is Index Component: GSPCOne Month Predict Return: >= 5.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Regions Financial Corp

24.74B

Bunge Global ltd

22.02B

Gilead Sciences Inc

176.11B

Ralph Lauren Corp

21.43B

United Parcel Service Inc

90.12B

Baker Hughes Co

55.30B

Any sector any risk

Intellectia · 39 candidates

Net Margin: >= 8.00Revenue 5yr Cagr: >= 8Pe Ttm: 10 - 30List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 12.0%Is Index Component: GSPC

Ticker

Name

Market Cap$

Micron Technology Inc

437.95B

Newmont Corporation

129.76B

Ulta Beauty Inc

30.32B

Monolithic Power Systems Inc

51.50B

Goldman Sachs Group Inc

285.83B

Charles Schwab Corp

180.87B

what company should invest in

Intellectia · 17 candidates

Market Cap: >= 10.00BDividend Yield Ttm: >= 1Revenue 5yr Cagr: >= 10Pe Ttm: <= 25Return On Equity: >= 15.0%

Ticker

Name

Market Cap$

UnitedHealth Group Inc

315.01B

Novo Nordisk A/S

263.42B

Charles Schwab Corp

180.87B

Banco Bilbao Vizcaya Argentaria SA

141.76B

Newmont Corporation

129.76B

ConocoPhillips

120.05B

show top 5 undervalued stock for growth

Intellectia · 93 candidates

Market Cap: >= 1000.00MRevenue 5yr Cagr: >= 10Eps 5yr Cagr: >= 10Weekly Average Turnover: >= 1,000,000Pe Ttm: <= 20P/B Ratio: <= 3.00

Ticker

Name

Market Cap$

Goldman Sachs Group Inc

285.83B

Banco Bilbao Vizcaya Argentaria SA

141.76B

Chubb Ltd

118.06B

ICICI Bank Ltd

104.54B

Regeneron Pharmaceuticals Inc

78.75B

Equinor ASA

64.15B

Intellectia · 28 candidates

Market Cap: >= 10.00BWeekly Average Turnover: >= 1,000,000Pe Ttm: 5 - 20Return On Equity: >= 10.0%

Ticker

Name

Market Cap$

JPMorgan Chase & Co

822.23B

Bank of America Corp

375.55B

Goldman Sachs Group Inc

285.83B

Wells Fargo & Co

266.33B

Royal Bank of Canada

235.24B

Banco Santander SA

178.90B

top stocks 10 stocks to put 1k into

Intellectia · 15 candidates

Market Cap: 10.00B - 200.00BDividend Yield Ttm: >= 1Revenue 5yr Cagr: >= 10Pe Ttm: <= 25Return On Equity: >= 15.0%

Ticker

Name

Market Cap$

Charles Schwab Corp

180.87B

Banco Bilbao Vizcaya Argentaria SA

141.76B

Newmont Corporation

129.76B

ConocoPhillips

120.05B

Progressive Corp

119.00B

NetEase Inc

83.31B

scan stock to buy for tomorrow

Intellectia · 15 candidates

Market Cap: >= 10.00BDividend Yield Ttm: >= 1Revenue 5yr Cagr: >= 10Pe Ttm: 10 - 25Return On Equity: >= 15.0%

Ticker

Name

Market Cap$

UnitedHealth Group Inc

315.01B

Novo Nordisk A/S

263.42B

Charles Schwab Corp

180.87B

Banco Bilbao Vizcaya Argentaria SA

141.76B

Newmont Corporation

129.76B

ConocoPhillips

120.05B

buy scan any stock

Intellectia · 15 candidates

Market Cap: >= 10.00BDividend Yield Ttm: >= 1Revenue 5yr Cagr: >= 10Pe Ttm: 10 - 25Return On Equity: >= 15.0%

Ticker

Name

Market Cap$

UnitedHealth Group Inc

315.01B

Novo Nordisk A/S

263.42B

Charles Schwab Corp

180.87B

Banco Bilbao Vizcaya Argentaria SA

141.76B

Newmont Corporation

129.76B

ConocoPhillips

120.05B

Whales Holding RJF

PRIMECAP Management Company

Palisade Capital Management, LP

New Age Alpha Advisors, LLC

Sterling Capital Management LLC

Basswood Capital Management, L.L.C.

CWA Asset Management Group, LLC

Trading Trends

Insider

Hedge Fund

Congress Trading

People Also Watch

Frequently Asked Questions

What is Raymond James Financial Inc (RJF) stock price today?

The current price of RJF is 167.6 USD — it has increased 0.72

What is Raymond James Financial Inc (RJF)'s business?

Raymond James Financial, Inc. is a diversified financial services company that provides services to individuals, corporations and municipalities. The Company's segments include Private Client Group (PCG), Capital Markets, Asset Management, Bank and Other. PCG segment provides financial planning, investment advisory, and securities transaction services to clients through financial advisors. Capital Markets segment conducts investment banking, institutional sales, securities trading, equity research, and the syndication and management of investments in low-income housing funds and funds of a similar nature. Asset Management segment provides asset management, portfolio management and related administrative services to retail and institutional clients. Bank segment includes Raymond James Bank, a Florida-chartered state member bank, and TriState Capital Bank, a Pennsylvania-chartered state member bank. Other segment includes corporate cash balances and its private equity investments.

What is the price predicton of RJF Stock?

Wall Street analysts forecast RJF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RJF is184.00 USD with a low forecast of 176.00 USD and a high forecast of 196.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Raymond James Financial Inc (RJF)'s revenue for the last quarter?

Raymond James Financial Inc revenue for the last quarter amounts to 4.17B USD, increased 10.88

What is Raymond James Financial Inc (RJF)'s earnings per share (EPS) for the last quarter?

Raymond James Financial Inc. EPS for the last quarter amounts to 2.72 USD, increased 15.25

How many employees does Raymond James Financial Inc (RJF). have?

Raymond James Financial Inc (RJF) has 19500 emplpoyees as of July 08 2026.

What is Raymond James Financial Inc (RJF) market cap?

Today RJF has the market capitalization of 32.66B USD.